Clinical Trial

Hereditary Influences on Pulmonary Fibrosis Trajectories

Name: Hereditary Influences on Pulmonary Fibrosis Trajectories — clinical trial record (NCT07580053)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SHIFT

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

The SHIFT (Hereditary Influences on Pulmonary Fibrosis Trajectories) study is a prospective, multicenter, observational cohort study designed to investigate familial pulmonary fibrosis (FPF) within the Italian population.

Trial Details

NCT Number	NCT07580053
Lead Sponsor	Istituto Clinico Humanitas Collaborators: University of Siena, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Ospedale San Paolo
Conditions	Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder), Idiopathic Pulmonary Fibrosis (IPF), Telomere Disease, Progressive Pulmonary Fibrosis, Familial Pulmonary Fibrosis
Enrollment	250 participants
Start Date	2026-04-01
Primary Completion	2034-12 (estimated)
Study Completion	2034-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-12